• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁螯合剂在病毒病治疗中的潜力:系统评价。

Therapeutic Potential of Iron Chelators in Viral Diseases: A Systematic Review.

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Kerman Medical Science University, Kerman, Iran.

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

Curr Med Chem. 2024;31(27):4383-4391. doi: 10.2174/0109298673259596231211113211.

DOI:10.2174/0109298673259596231211113211
PMID:38321902
Abstract

BACKGROUND

Iron chelators (ICs) have recently emerged as one of the new methods of treatment for viral infections. This study aimed to evaluate the efficiency and safety of natural ICs compared to synthetic ICs. Natural and synthetic ICs are the most common therapeutic agents tested for the treatment of viral infections. When evaluated against synthetic ICs, natural ICs are probably favored owing to their lower toxicity and safer properties. The main objective of the present systematic review was to assess the current evidence on the role of pharmacological mechanisms in the treatment of viral infections.

METHODS

This study was designed as a systematic review in which search strategies were focused on two electronic databases, PubMed, and Scopus, between 2017 and 2021. A search filter with two subjects, "iron chelators" and "viral infection", was employed.

RESULTS

According to the results, both natural and synthetic chelators had a considerable impact on the treatment of viral infections various mechanisms, with natural ICs being the most extensively used.

CONCLUSION

Natural and synthetic ICs exert their effects through different pharmacological mechanisms. Among these compounds, natural chelators are more widely used due to their safety, efficacy, and a wider range of applications.

摘要

背景

铁螯合剂(ICs)最近已成为治疗病毒感染的新方法之一。本研究旨在评估天然 IC 与合成 IC 的疗效和安全性。天然和合成 IC 是治疗病毒感染最常测试的治疗剂。与合成 IC 相比,天然 IC 可能因其毒性较低和安全性较高而受到青睐。本系统评价的主要目的是评估药理学机制在治疗病毒感染中的作用的现有证据。

方法

本研究设计为系统评价,其中搜索策略集中在 2017 年至 2021 年期间的两个电子数据库 PubMed 和 Scopus 上。使用了一个包含两个主题的搜索过滤器,“铁螯合剂”和“病毒感染”。

结果

根据结果,天然和合成螯合剂都通过不同的药理学机制对病毒感染的治疗产生了相当大的影响,其中天然 IC 应用最广泛。

结论

天然和合成 IC 通过不同的药理学机制发挥作用。在这些化合物中,由于其安全性、有效性和更广泛的应用范围,天然螯合剂的应用更为广泛。

相似文献

1
Therapeutic Potential of Iron Chelators in Viral Diseases: A Systematic Review.铁螯合剂在病毒病治疗中的潜力:系统评价。
Curr Med Chem. 2024;31(27):4383-4391. doi: 10.2174/0109298673259596231211113211.
2
Metal chelators as antiviral agents.金属螯合剂作为抗病毒剂。
Curr Opin Drug Discov Devel. 2007 Jul;10(4):460-72.
3
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.使用三价麦芽酚铁和其他亲脂性铁螯合剂复合物治疗缺铁性贫血的新时代:发现的历史视角和未来应用。
Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546.
4
Can iron chelators ameliorate viral infections?铁螯合剂可以改善病毒感染吗?
Biometals. 2024 Apr;37(2):289-304. doi: 10.1007/s10534-023-00558-x. Epub 2023 Nov 29.
5
The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects.去铁酮(L1)及其他临床用铁螯合剂的设计、开发:靶向方法与应用前景
Curr Med Chem. 2004 Aug;11(16):2161-83. doi: 10.2174/0929867043364685.
6
Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer.作为新型抗病毒和抗癌药物靶点的必需病毒和细胞含锌和含铁金属蛋白:对病毒疾病和癌症预防及治疗的意义。
Anticancer Res. 2001 Mar-Apr;21(2A):931-57.
7
Synthetic and natural iron chelators: therapeutic potential and clinical use.合成与天然铁螯合剂:治疗潜力与临床应用。
Future Med Chem. 2009 Dec;1(9):1643-70. doi: 10.4155/fmc.09.121.
8
Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?述评:铁螯合剂作为 COVID-19 治疗方案的辅助手段是否有效?
Metabolism. 2020 Jul;108:154260. doi: 10.1016/j.metabol.2020.154260. Epub 2020 May 8.
9
The role of iron chelation in cancer therapy.铁螯合在癌症治疗中的作用。
Curr Med Chem. 2003 Jun;10(12):1021-34. doi: 10.2174/0929867033457638.
10
The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency.天然和合成螯合剂在医学中的重要性和必要性:有效治疗铁过载和缺铁症的前景增加。
Int J Mol Sci. 2024 Apr 25;25(9):4654. doi: 10.3390/ijms25094654.

本文引用的文献

1
Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.乳铁蛋白,一种潜在的铁螯合剂,作为毛霉病的辅助治疗——全面综述。
Int J Biol Macromol. 2021 Sep 30;187:988-998. doi: 10.1016/j.ijbiomac.2021.07.156. Epub 2021 Jul 27.
2
Lactoferrin Against SARS-CoV-2: and Evidences.乳铁蛋白对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的作用及证据
Front Pharmacol. 2021 Jun 17;12:666600. doi: 10.3389/fphar.2021.666600. eCollection 2021.
3
The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators.
铁在 COVID-19 发病机制中的作用及乳铁蛋白和其他铁螯合剂的可能治疗作用。
Biomed Pharmacother. 2021 Apr;136:111228. doi: 10.1016/j.biopha.2021.111228. Epub 2021 Jan 13.
4
What Can Cellular Redox, Iron, and Reactive Oxygen Species Suggest About the Mechanisms and Potential Therapy of COVID-19?细胞氧化还原、铁和活性氧物种能告诉我们关于 COVID-19 的机制和潜在治疗方法的什么?
Front Cell Infect Microbiol. 2020 Dec 14;10:569709. doi: 10.3389/fcimb.2020.569709. eCollection 2020.
5
An overview of viruses discovered over the last decades and drug development for the current pandemic.过去几十年发现的病毒概述及当前大流行的药物研发。
Eur J Pharmacol. 2021 Jan 5;890:173746. doi: 10.1016/j.ejphar.2020.173746. Epub 2020 Nov 19.
6
Iron Metabolism in Ferroptosis.铁死亡中的铁代谢
Front Cell Dev Biol. 2020 Oct 7;8:590226. doi: 10.3389/fcell.2020.590226. eCollection 2020.
7
From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells.从铁螯合到铁过载作为诱导白血病细胞铁死亡的治疗策略。
Front Oncol. 2020 Sep 18;10:586530. doi: 10.3389/fonc.2020.586530. eCollection 2020.
8
Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections.病毒、微生物和真菌感染中的铁代谢途径及铁螯合方法
Pharmaceuticals (Basel). 2020 Sep 25;13(10):275. doi: 10.3390/ph13100275.
9
Reply: Iron chelation may harm patients with COVID-19.回复:铁螯合作用可能对新冠病毒患者造成伤害。
Eur J Clin Pharmacol. 2021 Feb;77(2):267-268. doi: 10.1007/s00228-020-02988-9. Epub 2020 Sep 1.
10
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
Immunol Res. 2020 Aug;68(4):213-224. doi: 10.1007/s12026-020-09145-5.